This document presents strategic guidelines and a development framework aimed at enhancing higher education programs in biotechnology within Bosnia and Herzegovina. It emphasizes the importance of aligning academic curricula, research capacities, and innovation ecosystems with global sustainable development goals (SDGs) and emerging scientific trends. Drawing on insights from the 2025 scientific-expert symposium "Next-Generation Biotechnologists – Skills of Future Educators," this work outlines key recommendations for modernizing educational approaches, strengthening interdisciplinary collaboration, and fostering the next generation of biotechnologists equipped to meet societal and technological challenges. The framework is intended for academic institutions, policymakers, and stakeholders committed to advancing biotechnology education and innovation in the region.

The chemical reactive molecule ROS (Reactive Oxygen Species) is a product of normal cellular metabolism. ROS plays a pivotal role in a wide range of biological processes, including aging, cancer and neurodegenerative diseases. Recent studies have shown that ROS can also affect the ribosomes – molecular machines responsible for protein synthesis.  ROS leads to errors in protein synthesis and the production of misfolded proteins, causing damage to ribosomes. However, it has also been suggested that ROS is implicated in the regulation of the ribosome activity under certain conditions. The aim of this paper is to review current knowledge regarding the effects of ROS on ribosomes, with a focus on the mechanisms by which ROS can cause damage to ribosomes and the potential role of ROS in regulating ribosome activity.

Leukemia represents the most prevalent malignancy in children, constituting 30% of childhood cancer cases, with acute lymphoblastic leukemia (ALL) being particularly heterogeneous. This paper explores the role of alternative splicing in leukemia, highlighting its significance in cancer development and progression. Aberrant splicing is often driven by mutations in splicing-factor genes, which can lead to the production of variant proteins that contribute to oncogenesis. The spliceosome, a complex of small nuclear RNAs and proteins, facilitates RNA splicing, a process critical for generating diverse mRNA and protein products from single genes. Mutations in splicing factors, such as U2AF1, SF3B1, SRSF2, ZRSR2, and HNRNPH1, are frequently observed across various hematological malignancies and are associated with poor prognosis and treatment resistance. This research underscores the necessity of understanding the mechanisms of RNA splicing dysregulation in order to develop targeted therapies to correct these aberrant processes, thereby improving outcomes for patients with leukemia and related disorders.

This research work presents a comprehensive overview of four traits related to the head, with the aim of assessing the statistical phenotypic association among them. The traits examined in this study encompass earlobe type, tongue rugosity, cleft chin and tongue rolling. The primary objective was to investigate the potential associations between these traits and understand their interrelationships. The study focused on examining specific traits in a diverse group of 7431 unrelated individuals, where the genders were almost evenly distributed. To facilitate a comprehensive analysis, three distinct groups were created for each characteristic, comprising the total population, as well as male and female subsets. The selection of subjects was carefully done to ensure a fair representation across different geographical regions within Bosnia and Herzegovina, thereby accurately reflecting the nation's national and ethnic diversity. The association among these traits was assessed for statistical significance using the Chi-squared test, with Fisher's exact test used as a supplementary method to examine the connection between each pair of observed traits. Additionally, the Chi-squared test was applied to examine gender-based differences in the frequencies of the phenotypic characteristics of the head. Following traits were shown to have a statistically significant association: tongue rugosity - tongue rolling, tongue rugosity – earlobe type, cleft chin – earlobe type, cleft chin – tongue rolling and earlobe type – tongue rolling. Investigation into the variations in the frequencies of observed phenotypic traits of the head, with respect to gender, revealed statistically significant results for every trait examined.

Introduction: Acute lymphoblastic leukemia (ALL) is the most frequent pediatric leukemia; it can be defined according to chromosomic and genomic data. Cytogenetic analyses and determination of chromosomal numbers (such as hypo- or hyperdiploidy) and/or specific chromosomal rearrangements are basic for ALL classification and treatment. Even though cure rates of childhood ALL are at ~95%, pharmacogenetic aspects are of raising importance. Material and Methods: We have analyzed the literature for ALL subtypes, corresponding therapy options, and pharmacogenetic implications. Results: Data for ALL subtypes such as B-ALL, T-ALL, Ph-like ALL, DS-ALL, ETP-ALL, BCR-ABL1-like ALL are presented here. The gene polymorphism which lead to metabolizability of 6-MP are ITPA variants (94C>A) and IVS2+21A>C, in conjunction with TPMT (238G>C, TPMT*3B 460G>A and *3C 719A>G and NUDT15 (415C>T). For methotrexate metabolism gene polymorphisms are found for gene MTHFR as C677T and A1298C. Conclusion: In the last decade in many hospital laboratories, pharmacogenetic aspects gain more and more importance. Application of many molecular biology methods provided progress in treatment and diagnosis of ALL patients. Combination therapy is proposed as an alternative to single drug treatments.

Systemic lupus erythematosus (SLE) is a disease associated with an impaired autoimmune response; the immune system attacks erroneously own tissues, which leads to inflammation, tissue damage and complement activation. The latter plays a pivotal role in SLE pathology, as complement level is suited as histological marker for disease diagnoses and management. Besides, environmentally factors have been highlighted and their significant contribution for individual genetic predisposition has been pointed out. Here complement factors, their activity and their ability to modify DNA with histone proteins are reviewed; known gene mutations involved in SLE, and new therapeutic approaches suggested for SLE are discussed and summarized, as well.